Market Spotlight

show blocks helper

Pain

Sort by Default

Display 15 Products per page

Market Spotlight: Neuropathic Pain

€1,241.16

This Market Spotlight report covers the neuropathic pain market, comprising key pipeline and marketed drugs, clinical trials, upcoming and regulatory events, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.
February 12, 2021
Find out more
Market Spotlight: Opioid-Induced Constipation

€1,241.16

This Market Spotlight report covers the Opioid-Induced Constipation market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, probability of success, licensing and asset acquisition deals, and epidemiology data, as well as presenting drug-specific revenue forecasts.
February 12, 2021
Find out more
Market Spotlight: Glaucoma

€1,241.16

This Market Spotlight report covers the Glaucoma market, comprising key pipeline and marketed drugs, clinical trials, upcoming and regulatory events, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.
February 11, 2021
Find out more
Market Spotlight: Tuberculosis (TB)

€1,241.16

This Market Spotlight report covers the Tuberculosis (TB) market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming and regulatory events, probability of success, a 10-year disease incidence forecast, and licensing and acquisition deals.
February 9, 2021
Find out more
Market Spotlight: Amyotrophic Lateral Sclerosis (ALS)

€1,241.16

This Market Spotlight report covers the Amyotrophic Lateral Sclerosis (ALS) market, comprising key marketed and pipeline drugs, clinical trials, upcoming and regulatory events, recent events and analyst opinion, a 10-year disease incidence forecast, probability of success, and licensing and acquisition deals.
February 9, 2021
Find out more
Market Spotlight: Ischemic Stroke

€1,241.16

This Market Spotlight report covers the Ischemic Stroke market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming and regulatory events, probability of success, and a 10-year disease prevalence forecast, as well as licensing and acquisition deals.
February 9, 2021
Find out more
Market Spotlight: Endometriosis

€1,241.16

This Market Spotlight report covers the Endometriosis market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming events, probability of success, a 10-year disease prevalence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.
January 21, 2021
Find out more
Market Spotlight: Huntington’s Disease

€1,241.16

This Market Spotlight report covers the Huntington’s disease market, comprising key marketed and pipeline drugs, clinical trials, upcoming and regulatory events, recent events and analyst opinion, probability of success, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.
January 21, 2021
Find out more
Market Spotlight: Fragile X Syndrome

€1,241.16

This Market Spotlight report covers the Fragile X Syndrome market, comprising key pipeline drugs, clinical trials, recent events and analyst opinion, upcoming events, probability of success, a discussion on disease epidemiology, and licensing and asset acquisition deals.
January 21, 2021
Find out more
Market Spotlight: Cold Agglutinin Disease

€1,241.16

This Market Spotlight report covers the Cold Agglutinin Disease market, comprising key pipeline drugs, clinical trials, probability of success, and an epidemiology overview.
January 21, 2021
Find out more
Market Spotlight: Coronary Artery Disease

€1,241.16

This Market Spotlight report covers the coronary artery disease market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, probability of success, patent information, 10-year disease prevalence and incidence forecasts, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.
January 21, 2021
Find out more
Market Spotlight: Myelofibrosis (MF)

€1,241.16

This Market Spotlight report covers the Myelofibrosis market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming and regulatory events, probability of success, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.
January 21, 2021
Find out more
Market Spotlight: Gout

€1,241.16

This Market Spotlight report covers the Gout market, comprising key marketed and pipeline drugs, clinical trials, upcoming events, recent events and analyst opinion, a 10-year disease prevalence forecast, probability of success, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.
January 21, 2021
Find out more
Market Spotlight: Mesothelioma

€1,241.16

This Market Spotlight report covers the mesothelioma market, comprising key pipeline and marketed drugs, clinical trials, upcoming and regulatory events, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.
January 21, 2021
Find out more
Market Spotlight: Glioblastoma (GBM)

€1,241.16

This Market Spotlight report covers the Glioblastoma (GBM) market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming and regulatory events, probability of success, a 10-year disease incidence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.
January 15, 2021
Find out more

Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!

Pharma Intelligence is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Call Back

Name

Email *

Company name *

Phone number *